Cancer | 2021
Survival advantage in patients with human papillomavirus‐driven oropharyngeal cancer and variation by demographic characteristics and serologic response: Findings from Head and Neck 5000
Abstract
Patients with human papillomavirus (HPV)‐driven oropharyngeal cancer (OPC) experience better survival than those with HPV‐negative OPC. It is unclear whether this benefit varies by demographic characteristics and serologic response.